TGF-β Secretion by M2 Macrophages Induces Glial Scar Formation by Activating Astrocytes In Vitro

• Published in: Journal of molecular neuroscience 2019-10, Vol.69 (2), p.324-332
• Main Authors: Song, Gongyu, Yang, Rui, Zhang, Qian, Chen, Long, Huang, Dujuan, Zeng, Junwei, Yang, Changpei, Zhang, Tao
• Format: Article
• Language: English
• Subjects: Animals; Astrocytes; Astrocytes - drug effects; Astrocytes - metabolism; Axons; Biomedical and Life Sciences; Biomedicine; Cell Biology; Cells, Cultured; Central nervous system; Cicatrix - metabolism; Coculture Techniques; Conditioning; Culture Media, Conditioned - pharmacology; Female; Fibrosis; Glial fibrillary acidic protein; Glial Fibrillary Acidic Protein - metabolism; Growth factors; Incubation; Injuries; Interleukin 13; Interleukin-13 - metabolism; Macrophages; Macrophages - metabolism; Male; Neurocan; Neurocan - metabolism; Neurochemistry; Neurology; Neuronal-glial interactions; Neurosciences; Proteins; Proteomics; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta - metabolism; Transforming growth factor-b
• ISSN: 0895-8696; 1559-1166
• DOI: 10.1007/s12031-019-01361-5

Transforming growth factor-β (TGF-β) is a key factor that promotes fibrosis or scar formation, which could become an obstacle in the repair of impaired axons in the central nervous system (CNS) of the human body resulting from diseases or injuries. Considering that major pathological reactions occur during this process, we focused on TGF-secreting M2 macrophages to identify the interactions between M2 macrophages and astrocytes (AS) and verify the specific mechanism of fibrosis or glial scar formation. In the present study, we used the Transwell coculturing technique and found an increase in glial fibrillary acidic protein (GFAP), neurocan, IL-13, and TGF-β expression after incubation for 48 h; the expression of these proteins decreased when additional inhibitors of the TGF-β receptor were added. We concluded that fibrosis or glial scar formation would be enhanced by the secretion of neurocan from AS, resulting from the release of TGF-β from M2 macrophages. We also used M2 macrophage–conditioned medium to further confirm this finding in a subsequent experiment. We hope that the findings in this research could provide a foundation for locating new targets for treating CNS diseases or injuries.